Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB SANOFI INDIA DR. REDDYS LAB/
SANOFI INDIA
 
P/E (TTM) x 19.7 31.0 63.6% View Chart
P/BV x 4.4 15.4 28.8% View Chart
Dividend Yield % 0.6 7.0 9.3%  

Financials

 DR. REDDYS LAB   SANOFI INDIA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
SANOFI INDIA
Dec-22
DR. REDDYS LAB/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs4,6567,939 58.6%   
Low Rs3,7885,454 69.4%   
Sales per share (Unadj.) Rs1,481.41,202.8 123.2%  
Earnings per share (Unadj.) Rs270.7269.5 100.4%  
Cash flow per share (Unadj.) Rs345.7287.7 120.2%  
Dividends per share (Unadj.) Rs40.00570.00 7.0%  
Avg Dividend yield %0.98.5 11.1%  
Book value per share (Unadj.) Rs1,389.6527.0 263.7%  
Shares outstanding (eoy) m166.5323.03 723.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.85.6 51.2%   
Avg P/E ratio x15.624.9 62.8%  
P/CF ratio (eoy) x12.223.3 52.5%  
Price / Book Value ratio x3.012.7 23.9%  
Dividend payout %14.8211.5 7.0%   
Avg Mkt Cap Rs m703,039154,224 455.9%   
No. of employees `000NANA-   
Total wages/salary Rs m46,4664,059 1,144.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,69727,701 890.6%  
Other income Rs m10,555730 1,445.9%   
Total revenues Rs m257,25228,431 904.8%   
Gross profit Rs m63,8608,349 764.9%  
Depreciation Rs m12,502419 2,983.8%   
Interest Rs m1,42817 8,400.0%   
Profit before tax Rs m60,4858,643 699.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,4122,437 632.4%   
Profit after tax Rs m45,0736,206 726.3%  
Gross profit margin %25.930.1 85.9%  
Effective tax rate %25.528.2 90.4%   
Net profit margin %18.322.4 81.6%  
BALANCE SHEET DATA
Current assets Rs m203,16136,121 562.4%   
Current liabilities Rs m85,72127,425 312.6%   
Net working cap to sales %47.631.4 151.6%  
Current ratio x2.41.3 179.9%  
Inventory Days Days79117 67.9%  
Debtors Days Days10717 630.5%  
Net fixed assets Rs m112,63812,148 927.2%   
Share capital Rs m833230 362.2%   
"Free" reserves Rs m230,57111,906 1,936.6%   
Net worth Rs m231,40412,136 1,906.8%   
Long term debt Rs m1,2780-   
Total assets Rs m315,79948,279 654.1%  
Interest coverage x43.4509.4 8.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 136.1%   
Return on assets %14.712.9 114.2%  
Return on equity %19.551.1 38.1%  
Return on capital %26.671.4 37.3%  
Exports to sales %52.214.1 370.5%   
Imports to sales %16.814.6 115.4%   
Exports (fob) Rs m128,8033,904 3,299.2%   
Imports (cif) Rs m41,4844,037 1,027.7%   
Fx inflow Rs m128,8033,904 3,299.2%   
Fx outflow Rs m41,4844,037 1,027.7%   
Net fx Rs m87,319-133 -65,777.0%   
CASH FLOW
From Operations Rs m58,8753,987 1,476.7%  
From Investments Rs m-41,3736,509 -635.6%  
From Financial Activity Rs m-26,861-15,827 169.7%  
Net Cashflow Rs m-9,073-5,331 170.2%  

Share Holding

Indian Promoters % 26.7 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 47.3 28.8 164.0%  
FIIs % 28.6 6.3 453.6%  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 39.6 146.5%  
Shareholders   257,794 62,870 410.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   CIPLA    DIVIS LABORATORIES    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs Sanofi India Share Price Performance

Period Dr. Reddys Sanofi India S&P BSE HEALTHCARE
1-Day 1.78% 2.06% 1.18%
1-Month -4.23% -8.09% -0.75%
1-Year 35.93% 44.45% 61.82%
3-Year CAGR 10.85% 0.97% 18.16%
5-Year CAGR 17.77% 7.07% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

Sanofi India paid Rs 570.0, and its dividend payout ratio stood at 211.5%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.